 |
FDA Approval Activities for this Drug
Lexiva (Fosamprenavir Calcium) Tablets, 700mg, GlaxoSmithKline NDA 21-548 Lexiva (Fosamprenavir Calcium) Tablets, GlaxoSmithKline | Lexiva (Fosamprenavir calcium) tablets, GlaxoSmithKline, Labeling Revision | Lexiva (fosamprenavir calcium) tablets, GlaxoSmithKline, Labeling Revision | Lexiva (fosamprenavir calcium) tablets, GlaxoSmithKline, Labeling Revision | Lexiva (fosamprenavir calcium) tablets, GlaxoSmithKline, Labeling Revision | Lexiva (fosamprenavir calcium) tablets, GlaxoSmithKline, Labeling Revision | Lexiva (fosamprenavir calcium) tablets, GlaxoSmithKline, Labeling Revision | Lexiva (fosamprenavir calcium) tablets, GlaxoSmithKline, Labeling Revision | Lexiva (fosamprenavir calcium) Oral Suspension, GlaxoSmithKline | LEXIVA (fosamprenavir calcium; FPV) Oral Tablets, GlaxoSmithKline, New Dosage Regimen | LEXIVA (fosamprenavir calcium) Oral Tablets, GlaxoSmithKline, Labeling Revision | LEXIVA (fosamprenavir calcium, FPV) Oral Tablets, GlaxoSmithKline, Labeling Revision | Lexiva (fosamprenavir calcium) Tablets, GlaxoSmithKline, Labeling Revision | Lexiva (fosamprenavir calcium) Tablets, GlaxoSmithKline, Labeling Revision | Lexiva (fosamprenavir calcium) Tablets, GlaxoSmithKline, Labeling Revision | Lexiva (fosamprenavir calcium) Oral Suspension, GlaxoSmithKline, Labeling Revision | Lexiva (fosamprenavir calcium) Tablets, GlaxoSmithKline, Labeling Revision | Lexiva (fosamprenavir calcium) Oral Suspension, GlaxoSmithKline, Labeling Revision | Lexiva (fosamprenavir calcium) Tablets, Glaxosmithkline Inc., Supplement | Lexiva (fosamprenavir calcium) Oral Suspension, Glaxosmithkline Inc., Supplement | Lexiva (fosamprenavir calcium) Tablets, ViiV Healthcare Company, Labeling Revision | Lexiva (fosamprenavir calcium) Tablets, ViiV Healthcare Company, Labeling Revision | Lexiva (fosamprenavir calcium) Oral Suspension, ViiV Healthcare Company, Labeling Revision
^ FDA's latest approval appears at the bottom of this list. ^
|